- A twice-yearly shot to control BP? Hypertension care is set to change India Today
- Quadpill Strategy Gains Ground in Hypertension Medscape
- Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption PLOS
- Pharmacist-Led Strategies Offer Solutions to Ongoing Hypertension Control Failures Pharmacy Times
- Anti-Hypertensive Drugs Market CAGR 3.25% (2025-2035): openPR.com
A twice-yearly shot to control BP? Hypertension care is set to change India TodayQuadpill Strategy Gains Ground in Hypertension MedscapeAldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption PLOSPharmacist-Led Strategies Offer Solutions to Ongoing Hypertension Control Failures Pharmacy TimesAnti-Hypertensive Drugs Market CAGR 3.25% (2025-2035): openPR.com by Soban News (international And National News)